Daniel A.J. Bow
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- PARP inhibition in cancer therapy
Papers in
- Oncology 16
- Drug Transport and Resistance Mechanisms 14
-
- Pharmacological Effects and Toxicity Studies 6
- Co-authors
- Kim L. R. Brouwer (2 shared papers)Jennifer L. Perry (3 shared papers)John B. Pritchard (3 shared papers)Dietrich O. R. KEPPLER (1 shared paper)Johan E. Palm (1 shared paper)Yurong Lai (1 shared paper)Keith A. Hoffmaster (1 shared paper)Bruno Stieger (1 shared paper)
- Journals
- Drug Metabolism and Disposition (4 papers)Journal of Pharmaceutical Sciences (3 papers)Xenobiotica (2 papers)Clinical and Translational Science (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Daniel A.J. Bow
21 papers receiving 669 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 192
- Oncology 420
- Pediatrics, Perinatology and Child Health 223
- Pharmaceutical Science 43
- Hepatology 48
Countries citing papers authored by Daniel A.J. Bow
This map shows the geographic impact of Daniel A.J. Bow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A.J. Bow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A.J. Bow more than expected).
Fields of papers citing papers by Daniel A.J. Bow
This network shows the impact of papers produced by Daniel A.J. Bow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A.J. Bow. The network helps show where Daniel A.J. Bow may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel A.J. Bow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 215 | |
| 2 | 2007 | 96 | |
| 3 | 2017 | 66 | |
| 4 | 2013 | 57 | |
| 5 | 2005 | 39 | |
| 6 | 2017 | 37 | |
| 7 | 2004 | 35 | |
| 8 | 2013 | 34 | |
| 9 | 2020 | 25 | |
| 10 | 2019 | 18 | |
| 11 | 2020 | 12 | |
| 12 | 2016 | 11 | |
| 13 | 2021 | 6 | |
| 14 | 2017 | 6 | |
| 15 | 2019 | 6 | |
| 16 | 2019 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2020 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2022 | 3 |
About Daniel A.J. Bow
Daniel A.J. Bow is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Hepatology, Infectious Diseases and Pharmacology, having authored 21 papers that have together received 683 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), HIV/AIDS drug development and treatment (7 papers), Pharmacological Effects and Toxicity Studies (6 papers), Hepatitis C virus research (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Renal Transplantation Outcomes and Treatments (2 papers), Protein Interaction Studies and Fluorescence Analysis (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). The work is most often cited by research in Pharmacology (192 citations), Oncology (420 citations), Pediatrics, Perinatology and Child Health (223 citations), Pharmaceutical Science (43 citations) and Hepatology (48 citations). Daniel A.J. Bow has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Kim L. R. Brouwer, Jennifer L. Perry, John B. Pritchard, Dietrich O. R. KEPPLER, Johan E. Palm, Yurong Lai, Keith A. Hoffmaster, Bruno Stieger, Yaofeng Cheng and Raymond Evers. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmaceutical Sciences, Xenobiotica, Clinical and Translational Science and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.